We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$62.1B
AUM Growth
+$2.92B
Cap. Flow
-$171M
Cap. Flow %
-0.28%
Top 10 Hldgs %
33.79%
Holding
4,220
New
148
Increased
1,007
Reduced
1,992
Closed
240

Sector Composition

Rank Sector Weight
1 Technology 12.93%
2 Healthcare 8.17%
3 Financials 7.02%
4 Industrials 5.53%
5 Consumer Staples 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOOK
3726
DELISTED
HOOKIPA Pharma
HOOK
$1.32K ﹤0.01%
150
BHVN icon
3727
Biohaven
BHVN
$2.16B
$1.32K ﹤0.01%
55
-75
-58% -$1.29K
HDSN
3728
Hudson Technologies
HDSN
$267M
$1.31K ﹤0.01%
136
ARKO icon
3729
ARKO Corp
ARKO
$890M
$1.3K ﹤0.01%
164
-523
-76% -$4.16K
OPY icon
3730
Oppenheimer Holdings
OPY
$1.17B
$1.29K ﹤0.01%
32
ANIX icon
3731
Anixa Biosciences
ANIX
$126M
$1.28K ﹤0.01%
400
LAZ icon
3732
Lazard
LAZ
$4.37B
$1.28K ﹤0.01%
40
-24
-38% -$742
TPB icon
3733
Turning Point Brands
TPB
$1.47B
$1.27K ﹤0.01%
53
ASTH icon
3734
Astrana Health
ASTH
$2B
$1.26K ﹤0.01%
40
-31
-44% -$1.06K
VPG icon
3735
Vishay Precision Group
VPG
$1.39B
$1.26K ﹤0.01%
+34
New +$1.27K
CDMO
3736
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.24K ﹤0.01%
89
-5,942
-99% -$101K
AX icon
3737
Axos Financial
AX
$5.45B
$1.22K ﹤0.01%
31
-1,373
-98% -$53.2K
SWI
3738
DELISTED
SolarWinds Corporation Common Stock
SWI
$1.19K ﹤0.01%
116
NGM
3739
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$1.17K ﹤0.01%
452
-1,209
-73% -$4.31K
LXFR icon
3740
Luxfer Holdings
LXFR
$460M
$1.17K ﹤0.01%
82
-68
-45% -$1.04K
WTTR icon
3741
Select Water Solutions
WTTR
$2.51B
$1.17K ﹤0.01%
144
OFIX icon
3742
Orthofix Medical
OFIX
$455M
$1.16K ﹤0.01%
+64
New +$1.2K
MCS icon
3743
Marcus Corp
MCS
$732M
$1.14K ﹤0.01%
77
INO icon
3744
Inovio Pharmaceuticals
INO
$79.8M
$1.14K ﹤0.01%
213
-190
-47% -$1.53K
TVTX icon
3745
Travere Therapeutics
TVTX
$5.33B
$1.14K ﹤0.01%
74
-294
-80% -$5.35K
CRNX icon
3746
Crinetics Pharmaceuticals
CRNX
$8.86B
$1.14K ﹤0.01%
63
-87
-58% -$1.74K
CRBU icon
3747
Caribou Biosciences
CRBU
$156M
$1.11K ﹤0.01%
261
-503
-66% -$2.26K
ERAS icon
3748
Erasca
ERAS
$6.63B
$1.09K ﹤0.01%
394
-584
-60% -$1.66K
PTGX icon
3749
Protagonist Therapeutics
PTGX
$8.75B
$1.08K ﹤0.01%
+39
New +$976
COUR icon
3750
Coursera
COUR
$1.54B
$1.07K ﹤0.01%
82

Similar funds

US Bancorp's Q2 2023 Portfolio in Review

As of Q2 2023, US Bancorp held 4,220 positions worth $62.1B, up 4.9% from $59.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

US Bancorp's Q2 2023 filing shows 148 new, 1,007 increased, 1,992 reduced and 240 closed positions. Its largest new stake was Knife River: 440,189 shares worth $19.1M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $409M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • US Bancorp's largest Q2 2023 buy was Knife River: 440,189 shares worth $19.1M.
  • US Bancorp added most to Vanguard Total Stock Market ETF in Q2 2023, an estimated $1.11B increase.
  • US Bancorp's biggest Q2 2023 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $409M.
  • US Bancorp fully exited ABB Ltd in Q2 2023, selling an estimated $5.54M.
  • US Bancorp's ten largest holdings make up 34% of its $62.1B portfolio in Q2 2023.
  • US Bancorp opened 148 new positions and closed 240 in Q2 2023.
  • US Bancorp's portfolio value rose 4.9% quarter-over-quarter to $62.1B.

Based on US Bancorp's 13F filing for Q2 2023, filed 10 Aug 2023.